STOCK TITAN

Cardinal Health Inc - CAH STOCK NEWS

Welcome to our dedicated page for Cardinal Health news (Ticker: CAH), a resource for investors and traders seeking the latest updates and insights on Cardinal Health stock.

Cardinal Health (NYSE: CAH), a leader in pharmaceutical distribution and healthcare supply chain solutions, maintains this dedicated news hub for investors and industry stakeholders. Our continuously updated repository provides official press releases, regulatory filings, and market-moving developments.

This resource delivers critical updates across CAH's core operations including pharmaceutical network expansions, medical-surgical product innovations, and strategic healthcare partnerships. Users gain access to essential documents such as quarterly earnings reports, SEC filings, and leadership announcements.

Key coverage areas include operational milestones in specialty drug distribution, advancements in clinical supply chain technology, and regulatory updates affecting global healthcare logistics. The curated format enables efficient tracking of CAH's market position within the competitive medical distribution sector.

Bookmark this page for direct access to primary-source Cardinal Health communications, ensuring informed decision-making through verified company disclosures. Combine regular monitoring with SEC.gov filings for comprehensive investment research.

Rhea-AI Summary

Cardinal Health (CAH) reported Q1 FY2025 results with revenue decreasing 4% to $52.3 billion, though showing 15% growth excluding a large customer contract expiration. Non-GAAP operating earnings increased 12% to $625 million, driven by Pharmaceutical and Specialty Solutions segment growth. Non-GAAP diluted EPS rose 9% to $1.88. The company raised its FY2025 non-GAAP EPS guidance to $7.75-$7.90. Notable developments include a $1.1B agreement to acquire Integrated Oncology Network and completion of a $375M accelerated share repurchase program.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.01%
Tags
-
Rhea-AI Summary

Cardinal Health (NYSE: CAH) has opened a new distribution center in Boylston, Massachusetts, replacing its Bedford facility with nearly 317,000 square feet of space. The new center doubles warehouse space and triples product storage capacity, serving healthcare customers across New England. Opening in early 2025, it features specialized handling capabilities including refrigeration and hazardous materials storage.

The facility enhances supply chain resiliency and operational efficiency for the region's healthcare providers. This expansion follows Cardinal Health's recent openings of a 310,000-square-foot replenishment center in Montgomery, New York (2023), and announcements of new distribution centers in Walton Hills, Ohio, and Greenville, South Carolina.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.73%
Tags
none
-
Rhea-AI Summary

Cardinal Health (NYSE: CAH) has announced that it will release its first-quarter financial results for fiscal year 2025 on November 1, before the New York Stock Exchange opens for trading. The company will host a webcast discussion of the results at 8:30 a.m. Eastern. Investors can access the webcast and accompanying slide presentation through Cardinal Health's Investor Relations page, with no access code required. The presentation slides and a replay of the webcast will remain available on the Investor Relations page for 12 months following the event.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.48%
Tags
Rhea-AI Summary

Cardinal Health (NYSE: CAH) has announced a definitive agreement to acquire Integrated Oncology Network (ION) for $1.115 billion in cash. ION is a physician-led independent community oncology network with over 50 practice sites across 10 states, representing more than 100 providers. This acquisition aligns with Cardinal Health's strategy to invest in specialty and oncology services, particularly supporting independent community healthcare providers.

The transaction will integrate ION practices into Navista, Cardinal Health's oncology practice alliance. ION's comprehensive care services, including medical oncology, radiation oncology, and urology, will enhance Navista's advanced services and technology offerings. The acquisition is expected to be accretive to non-GAAP earnings per share after 12 months following the close, subject to customary closing conditions and regulatory approvals.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.98%
Tags
-
Rhea-AI Summary

Children's Hospital Association (CHA), Cardinal Health (NYSE: CAH), and Zero Suicide Institute (ZSI) commemorate World Suicide Prevention Day by highlighting the success of their Preventing Youth Suicide Collaborative. Since 2022, 30 children's hospitals have screened nearly 320,000 children, with 15% requiring mental health support. ZSI developed a Zero Suicide Toolkit for Children's Hospitals to aid implementation strategies.

Suicide is now the second leading cause of death among 10- to 24-year-olds, according to the CDC. The collaborative aims to provide early detection, better screening, and timely intervention. Participating hospitals, like Phoenix Children's and Valley Children's Healthcare, have implemented comprehensive screening processes.

CHA urges Congress to pass the EARLY Minds Act and the Helping Kids Cope Act to prioritize youth mental health and improve care availability.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.39%
Tags
none
-
Rhea-AI Summary

Cardinal Health (NYSE: CAH) has officially opened a new distribution center in Greenville, South Carolina, dedicated to its at-Home Solutions business. This 350,000 square foot facility, the largest for the at-Home Solutions division, is expected to create approximately 200 jobs over time. The center will support the growing home healthcare industry, projected to reach $176.3 billion by 2032.

The facility will utilize advanced automation, AI, and robotics to ship nearly 8,000 packages daily directly to patients' homes. These packages include critical medical supplies such as diabetic equipment, incontinence and ostomy supplies, and enteral nutrition products. This expansion aligns with the increasing demand for home healthcare services, driven by America's aging population and the rising prevalence of chronic conditions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.87%
Tags
none
Rhea-AI Summary

Cardinal Health (NYSE: CAH) has announced plans to open a new 249,000 square foot distribution center in Walton Hills, Ohio, expanding its medical product distribution footprint in Northeast Ohio. The facility, set to be fully operational by spring 2025, will be over 30% larger than the Solon, Ohio location it replaces. It will feature advanced technology and automation to improve service quality, enhance employee work experiences, and increase storage capacity.

This expansion is part of Cardinal Health's broader strategy to improve infrastructure, warehouse operations, and supply chain resiliency. The company has recently opened new distribution centers in Central Ohio and Montgomery, N.Y., with another facility opening soon in the Boston area. These investments demonstrate Cardinal Health's commitment to meeting growing customer needs and strengthening its U.S. Medical Products and Distribution business.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.71%
Tags
none
-
Rhea-AI Summary

Cardinal Health (NYSE: CAH) has announced that its Board of Directors has approved a quarterly dividend of $0.5056 per share. This dividend will be paid out of the company's capital surplus. Shareholders who are on record at the close of business on October 1, 2024, will receive the dividend payment on October 15, 2024. This announcement demonstrates Cardinal Health's commitment to returning value to its shareholders through regular dividend payments.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.8%
Tags
management dividends
-
Rhea-AI Summary

Cardinal Health (NYSE: CAH) reported strong Q4 and FY2024 results, raising its FY2025 guidance. Q4 revenue increased 12% to $59.9 billion, with non-GAAP operating earnings up 14% to $605 million. Non-GAAP diluted EPS rose 29% to $1.84. For FY2024, revenue grew 11% to $226.8 billion, non-GAAP operating earnings increased 16% to $2.4 billion, and non-GAAP diluted EPS climbed 29% to $7.53.

The company achieved record operating cash flow of $3.8 billion and adjusted free cash flow of $3.9 billion. Cardinal Health raised its FY2025 non-GAAP EPS guidance to $7.55-$7.70, up from at least $7.50 previously. The Pharmaceutical and Specialty Solutions segment saw 13% revenue growth in Q4, while Global Medical Products and Distribution segment profit significantly improved.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.68%
Tags
Rhea-AI Summary

Cardinal Health (NYSE: CAH) has announced that it will release its fourth-quarter and year-end financial results for fiscal year 2024 on August 14, 2024, before the opening of trading on the New York Stock Exchange. The company will host a webcast discussion of the results starting at 8:30 a.m. Eastern.

Investors and interested parties can access the webcast and accompanying slide presentation through Cardinal Health's Investor Relations page. No access code is required for participation. The presentation slides and a replay of the webcast will remain available on the Investor Relations page for 12 months following the event.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.44%
Tags

FAQ

What is the current stock price of Cardinal Health (CAH)?

The current stock price of Cardinal Health (CAH) is $139.84 as of April 29, 2025.

What is the market cap of Cardinal Health (CAH)?

The market cap of Cardinal Health (CAH) is approximately 31.7B.
Cardinal Health Inc

NYSE:CAH

CAH Rankings

CAH Stock Data

31.69B
240.93M
0.25%
89.03%
2.68%
Medical Distribution
Wholesale-drugs, Proprietaries & Druggists' Sundries
Link
United States
DUBLIN